Skip to main content
Erschienen in: Abdominal Radiology 2/2019

20.08.2018

Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis

verfasst von: Jonathan C. Hooker, Gavin Hamilton, Charlie C. Park, Steven Liao, Tanya Wolfson, Soudabeh Fazeli Dehkordy, Cheng William Hong, Adrija Mamidipalli, Anthony Gamst, Rohit Loomba, Claude B. Sirlin

Erschienen in: Abdominal Radiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the inter-reader agreement of magnetic resonance imaging proton density fat fraction (PDFF) and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis (NASH).

Study type

We performed a secondary analysis of a placebo-controlled randomized clinical trial of a bile acid sequestrant in 45 adults with NASH. A six-echo spoiled gradient-recalled-echo magnitude-based fat quantification technique was performed at 3 T. Three independent readers measured MRI-PDFF by placing one primary and two additional regions of interest (ROIs) in each segment at both time points. Cross-sectional agreement between the three readers was evaluated using intra-class correlation coefficients (ICCs) and coefficients of variation (CV). Additionally, we used Bland–Altman analyses to examine pairwise agreement between the three readers at baseline, end of treatment (EOT), and for longitudinal change.

Results

Using all ROIs by all readers, mean PDFF at baseline, at EOT, and mean change in PDFF was 16.1%, 16.0%, and 0.07%, respectively. The 27-ROI PDFF measurements had 0.998 ICC and 1.8% CV at baseline, 0.998 ICC and 1.8% CV at EOT, and 0.997 ICC for longitudinal change. The 9-ROI PDFF measurements had corresponding values of 0.997 and 2.6%, 0.996 and 2.4%, and 0.994. Using 27 ROIs, the magnitude of the bias between readers for whole-liver PDFF measurement ranged from 0.03% to 0.06% points at baseline, 0.01% to 0.07% points at EOT, and 0.01% to 0.02% points for longitudinal change.

Conclusion

Inter-reader agreement for measuring whole-liver PDFF and its longitudinal change is high. 9-ROI measurements have only slightly lower agreement than 27-ROI measurements.
Literatur
1.
Zurück zum Zitat Tang A, Tan J, Sun M, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267(2):422–431PubMedPubMedCentralCrossRef Tang A, Tan J, Sun M, et al. (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267(2):422–431PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Tang A, Desai A, Hamilton G, et al. (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274(2):416–425PubMedCrossRef Tang A, Desai A, Hamilton G, et al. (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274(2):416–425PubMedCrossRef
3.
Zurück zum Zitat Schwimmer JB, Middleton MS, Behling C, et al. (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61(6):1887–1895PubMedPubMedCentralCrossRef Schwimmer JB, Middleton MS, Behling C, et al. (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61(6):1887–1895PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Idilman IS, Aniktar H, Idilman R, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267(3):767–775PubMedCrossRef Idilman IS, Aniktar H, Idilman R, et al. (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267(3):767–775PubMedCrossRef
5.
Zurück zum Zitat Rehm JL, Wolfgram PM, Hernando D, et al. (2015) Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 25(10):2921–2930PubMedPubMedCentralCrossRef Rehm JL, Wolfgram PM, Hernando D, et al. (2015) Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 25(10):2921–2930PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Bydder M, Yokoo T, Hamilton G, et al. (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26(3):347–359PubMedPubMedCentralCrossRef Bydder M, Yokoo T, Hamilton G, et al. (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26(3):347–359PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Hamilton G, Yokoo T, Bydder M, et al. (2011) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24(7):784–790PubMedCrossRef Hamilton G, Yokoo T, Bydder M, et al. (2011) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24(7):784–790PubMedCrossRef
8.
Zurück zum Zitat Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34(4):spconePubMedPubMedCentralCrossRef Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34(4):spconePubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Artz NS, Haufe WM, Hooker CA, et al. (2015) Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5 T and 3 T in obese subjects. J Magn Reson Imaging 42(3):811–817PubMedPubMedCentralCrossRef Artz NS, Haufe WM, Hooker CA, et al. (2015) Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5 T and 3 T in obese subjects. J Magn Reson Imaging 42(3):811–817PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Reeder SB, McKenzie CA, Pineda AR, et al. (2007) Water–fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25(3):644–652PubMedCrossRef Reeder SB, McKenzie CA, Pineda AR, et al. (2007) Water–fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25(3):644–652PubMedCrossRef
11.
Zurück zum Zitat Yu H, Shimakawa A, Hines CD, et al. (2011) Combination of complex-based and magnitude-based multiecho water–fat separation for accurate quantification of fat-fraction. Magn Reson Med 66(1):199–206PubMedPubMedCentralCrossRef Yu H, Shimakawa A, Hines CD, et al. (2011) Combination of complex-based and magnitude-based multiecho water–fat separation for accurate quantification of fat-fraction. Magn Reson Med 66(1):199–206PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Yokoo T, Bydder M, Hamilton G, et al. (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251(1):67–76PubMedPubMedCentralCrossRef Yokoo T, Bydder M, Hamilton G, et al. (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251(1):67–76PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Yokoo T, Shiehmorteza M, Hamilton G, et al. (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258(3):749–759PubMedPubMedCentralCrossRef Yokoo T, Shiehmorteza M, Hamilton G, et al. (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258(3):749–759PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Permutt Z, Le TA, Peterson MR, et al. (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36(1):22–29PubMedPubMedCentralCrossRef Permutt Z, Le TA, Peterson MR, et al. (2012) Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36(1):22–29PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Negrete LM, Middleton MS, Clark L, et al. (2014) Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging 39(5):1265–1271PubMedCrossRef Negrete LM, Middleton MS, Clark L, et al. (2014) Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging 39(5):1265–1271PubMedCrossRef
16.
Zurück zum Zitat Tyagi A, Yeganeh O, Levin Y, et al. (2015) Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging 40(8):3070–3077PubMedPubMedCentralCrossRef Tyagi A, Yeganeh O, Levin Y, et al. (2015) Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging 40(8):3070–3077PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Kang GH, Cruite I, Shiehmorteza M, et al. (2011) Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 34(4):928–934PubMedPubMedCentralCrossRef Kang GH, Cruite I, Shiehmorteza M, et al. (2011) Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 34(4):928–934PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Le TA, Chen J, Changchien C, et al. (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56(3):922–932PubMedPubMedCentralCrossRef Le TA, Chen J, Changchien C, et al. (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56(3):922–932PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Cui J, Philo L, Nguyen P, et al. (2016) Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 65(2):369–376PubMedPubMedCentralCrossRef Cui J, Philo L, Nguyen P, et al. (2016) Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 65(2):369–376PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Tang A, Rabasa-Lhoret R, Castel H, et al. (2015) Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial. Diabetes Care 38(7):1339–1346PubMedCrossRef Tang A, Rabasa-Lhoret R, Castel H, et al. (2015) Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial. Diabetes Care 38(7):1339–1346PubMedCrossRef
21.
Zurück zum Zitat Loomba R, Sirlin CB, Ang B, et al. (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61(4):1239–1250PubMedPubMedCentralCrossRef Loomba R, Sirlin CB, Ang B, et al. (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61(4):1239–1250PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Meisamy S, Hines CD, Hamilton G, et al. (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258(3):767–775PubMedPubMedCentralCrossRef Meisamy S, Hines CD, Hamilton G, et al. (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258(3):767–775PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Middleton MS, Heba ER, Hooker CA, et al. (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153(3):753–761PubMedPubMedCentralCrossRef Middleton MS, Heba ER, Hooker CA, et al. (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153(3):753–761PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Bonekamp S, Tang A, Mashhood A, et al. (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39(6):1525–1532PubMedPubMedCentralCrossRef Bonekamp S, Tang A, Mashhood A, et al. (2014) Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease. J Magn Reson Imaging 39(6):1525–1532PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Sofue K, Mileto A, Dale BM, Zhong X, Bashir MR (2015) Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm. J Magn Reson Imaging 42(5):1281–1290PubMedCrossRef Sofue K, Mileto A, Dale BM, Zhong X, Bashir MR (2015) Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm. J Magn Reson Imaging 42(5):1281–1290PubMedCrossRef
27.
Zurück zum Zitat Arulanandan A, Ang B, Bettencourt R, et al (2015) Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 13(8):1513–1520 e1511 Arulanandan A, Ang B, Bettencourt R, et al (2015) Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 13(8):1513–1520 e1511
28.
Zurück zum Zitat Vu KN, Gilbert G, Chalut M, et al. (2016) MRI-determined liver proton density fat fraction, with MRS validation: comparison of regions of interest sampling methods in patients with type 2 diabetes. J Magn Reson Imaging 43(5):1090–1099PubMedCrossRef Vu KN, Gilbert G, Chalut M, et al. (2016) MRI-determined liver proton density fat fraction, with MRS validation: comparison of regions of interest sampling methods in patients with type 2 diabetes. J Magn Reson Imaging 43(5):1090–1099PubMedCrossRef
29.
Zurück zum Zitat Noureddin M, Lam J, Peterson MR, et al. (2013) Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58(6):1930–1940PubMedPubMedCentralCrossRef Noureddin M, Lam J, Peterson MR, et al. (2013) Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58(6):1930–1940PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Serai SD, Dillman JR, Trout AT (2017) Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers. Radiology 284(1):244–254PubMedCrossRef Serai SD, Dillman JR, Trout AT (2017) Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers. Radiology 284(1):244–254PubMedCrossRef
32.
Zurück zum Zitat Johnson BL, Schroeder ME, Wolfson T, et al. (2014) Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging 39(2):440–447PubMedCrossRef Johnson BL, Schroeder ME, Wolfson T, et al. (2014) Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging 39(2):440–447PubMedCrossRef
33.
Zurück zum Zitat Hines CD, Frydrychowicz A, Hamilton G, et al. (2011) T(1) independent, T(2) (*) corrected chemical shift based fat–water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33(4):873–881PubMedPubMedCentralCrossRef Hines CD, Frydrychowicz A, Hamilton G, et al. (2011) T(1) independent, T(2) (*) corrected chemical shift based fat–water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33(4):873–881PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Merriman RB, Ferrell LD, Patti MG, et al. (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44(4):874–880PubMedCrossRef Merriman RB, Ferrell LD, Patti MG, et al. (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44(4):874–880PubMedCrossRef
35.
Zurück zum Zitat Ratziu V, Charlotte F, Heurtier A, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128(7):1898–1906PubMedCrossRef Ratziu V, Charlotte F, Heurtier A, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128(7):1898–1906PubMedCrossRef
36.
Zurück zum Zitat Juluri R, Vuppalanchi R, Olson J, et al. (2011) Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 45(1):55–58PubMedPubMedCentralCrossRef Juluri R, Vuppalanchi R, Olson J, et al. (2011) Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 45(1):55–58PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Pournik O, Alavian SM, Ghalichi L, et al. (2014) Inter-observer and intra-observer agreement in pathological evaluation of non-alcoholic fatty liver disease suspected liver biopsies. Hepat Mon 14(1):e15167PubMedPubMedCentralCrossRef Pournik O, Alavian SM, Ghalichi L, et al. (2014) Inter-observer and intra-observer agreement in pathological evaluation of non-alcoholic fatty liver disease suspected liver biopsies. Hepat Mon 14(1):e15167PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Am J Roentgenol 189(6):W320–W323CrossRef Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Am J Roentgenol 189(6):W320–W323CrossRef
39.
Zurück zum Zitat Manning PM, Hamilton G, Wang K, et al. (2017) Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease. Abdom Radiol (NY) 42(3):833–841CrossRef Manning PM, Hamilton G, Wang K, et al. (2017) Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease. Abdom Radiol (NY) 42(3):833–841CrossRef
Metadaten
Titel
Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis
verfasst von
Jonathan C. Hooker
Gavin Hamilton
Charlie C. Park
Steven Liao
Tanya Wolfson
Soudabeh Fazeli Dehkordy
Cheng William Hong
Adrija Mamidipalli
Anthony Gamst
Rohit Loomba
Claude B. Sirlin
Publikationsdatum
20.08.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 2/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1745-3

Weitere Artikel der Ausgabe 2/2019

Abdominal Radiology 2/2019 Zur Ausgabe

Classics in Abdominal Radiology

The central dot sign of epiploic appendagitis

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.